Position in ARGX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$6,329,807
-$539,072 QoQ
Shares Held
8,668
+6.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Crossmark Global Holdings, Inc. holds $39,668,975 across 33 Biotechnology names. ARGX ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
83,415 | $7,851,019 | |
| 2 | ARGX |
Argenx SE
This page
|
8,668 | $6,329,807 | |
| 3 | EXEL |
Exelixis, Inc.
|
79,230 | $3,398,174 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
51,090 | $2,886,074 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
7,661 | $2,275,087 | |
| 6 | ASND |
Ascendis Pharma A/S
|
7,783 | $1,780,205 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
6,534 | $1,235,252 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,704 | $1,207,444 |
All Filings in ARGX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,329,807 | 8,668 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,868,879 | 8,168 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $6,657,954 | 9,027 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,619,687 | 10,195 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,794,358 | 9,790 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $5,974,110 | 9,714 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $5,129,160 | 9,462 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,030,218 | 4,721 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,971,355 | 5,007 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,970,246 | 5,179 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,624,811 | 5,339 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,421,392 | 6,213 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,236,970 | 6,004 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,046,818 | 5,403 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,957,662 | 5,545 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,167,950 | 5,722 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,767,942 | 5,607 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,776,864 | 5,074 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $1,710,830 | 5,665 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,583,628 | 5,260 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,498,672 | 5,442 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,665,137 | 5,662 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $1,439,397 | 5,483 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $1,278,180 | 5,675 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||